Patents by Inventor Wenhao Cui

Wenhao Cui has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SIRNA FOR TREATING HEPATIC FIBROSIS AND DELIVERY PREPARATION THEREOF
    Publication number: 20230416753
    Abstract: Provided is a siRNA targeting a NOX1 protein for inhibiting the production of reactive oxygen species (ROS) to treat hepatic fibrosis. In addition, the siRNA has an improved effect on the treatment of hepatic fibrosis and non-alcoholic fatty liver.
    Type: Application
    Filed: November 19, 2021
    Publication date: December 28, 2023
    Applicant: YOUJIA (HANGZHOU) BIOMEDICAL TECHNOLOGY CO., LTD
    Inventors: Wenhao CUI, Chengjiang ZHAO, Meng WANG, Zhi ZHENG, Huandong TIAN
  • Method for treating spinal cord injury using HMGB1 fragment
    Patent number: 9688733
    Abstract: Fragment peptides having a proper length, which consists of a portion of the HMGB1 protein were synthesized, and the peptides were confirmed to show therapeutic effects on injury of the spinal cord.
    Type: Grant
    Filed: October 24, 2013
    Date of Patent: June 27, 2017
    Assignees: GENOMIX CO., LTD., OSAKA UNIVERSITY
    Inventors: Katsuto Tamai, Takehiko Yamazaki, Wenhao Cui
  • Novel Method for Treating Spinal Cord Injury Using HMGB1 Fragment
    Publication number: 20150274792
    Abstract: Fragment peptides having a proper length, which consists of a portion of the HMGB1 protein were synthesized, and the peptides were confirmed to show therapeutic effects on injury of the spinal cord.
    Type: Application
    Filed: October 24, 2013
    Publication date: October 1, 2015
    Inventors: Katsuto Tamai, Takehiko Yamazaki, Wenhao Cui